Literature DB >> 32241070

Management of HIV-positive pregnant women: a Singapore experience.

Michelle Loh1, Koh Cheng Thoon2,3,4, Manisha Mathur1,3,4,5, Rajeswari Kathirvel1,3,4,5.   

Abstract

INTRODUCTION: Perinatal transmission remains one of the important causes of transmission of the human immunodeficiency virus (HIV). Over the years, with better knowledge and awareness of HIV infection, the perinatal transmission rate has been significantly reduced. We previously reported on the pregnancy outcomes of HIV-positive mothers from 1997 to 2007 in our institution. This article aimed to review the standards of care of HIV-positive pregnant women since then.
METHODS: A retrospective study reviewed 84 HIV-positive women who delivered in a tertiary centre from January 2008 to December 2015. Patient demographics and antenatal, intrapartum, postnatal and immediate neonatal data were analysed.
RESULTS: A total of 97 deliveries with 98 neonates were recorded; 12 women delivered more than once, and there was one set of twins. The mean maternal age at diagnosis of HIV infection was 27.8 years. Of the study population, 63.1% of women were non-Singaporeans. 56 women were known to have HIV infection on presentation and 90.7% were on antiretroviral therapy during pregnancy. 88.7% of the women received intrapartum intravenous zidovudine, and 93.1% of women with detectable and 58.7% with undetectable viral load underwent Caesarean sections. All neonates were HIV-negative.
CONCLUSION: The high standards of care for HIV-positive women have successfully reduced our perinatal transmission rate to zero. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  HIV; pregnancy; prevention; vertical transmission

Mesh:

Substances:

Year:  2020        PMID: 32241070      PMCID: PMC8804419          DOI: 10.11622/smedj.2020048

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  10 in total

1.  ACOG Practice Bulletin No. 86: Viral hepatitis in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-10       Impact factor: 7.661

2.  Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study.

Authors:  S H Landesman; L A Kalish; D N Burns; H Minkoff; H E Fox; C Zorrilla; P Garcia; M G Fowler; L Mofenson; R Tuomala
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

3.  Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Authors:  Ellen R Cooper; Manhattan Charurat; Lynne Mofenson; I Celine Hanson; Jane Pitt; Clemente Diaz; Karen Hayani; Edward Handelsman; Vincent Smeriglio; Rodney Hoff; William Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

4.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

6.  Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.

Authors:  Victor Mwapasa; Stephen J Rogerson; Jesse J Kwiek; Paul E Wilson; Danny Milner; Malcolm E Molyneux; Deborah D Kamwendo; Eyob Tadesse; Ebbie Chaluluka; Steven R Meshnick
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

7.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Authors:  Henry Masur; Jonathan E Kaplan; King K Holmes
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

8.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?

Authors:  Nelly Briand; Josiane Warszawski; Laurent Mandelbrot; Catherine Dollfus; Emmanuelle Pannier; Ludovic Cravello; Rose Nguyen; Isabelle Matheron; Norbert Winer; Roland Tubiana; Christine Rouzioux; Albert Faye; Stéphane Blanche
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.